| Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637) |
|---|
| 02/21/2012 | US8119396 Recombinant adenoviral vectors and applications thereof |
| 02/21/2012 | US8119388 Non-tumorigenic MDCK cell line for propagating viruses |
| 02/21/2012 | US8119366 Antennapedia-dominant negative mastermind-like construct |
| 02/21/2012 | US8119118 Helper virus-free herpesvirus amplicon particles and uses thereof |
| 02/21/2012 | CA2495909C Nucleic acid damage using riboflavin and light |
| 02/21/2012 | CA2409983C Viral variants and methods of using same |
| 02/21/2012 | CA2373300C Compositions and methods for generating an immune response utilizing alphavirus-based vector systems |
| 02/21/2012 | CA2349760C Bovine cells expressing adeno virus essential functions for propagation of recombinant adenoviral vectors |
| 02/16/2012 | WO2012021783A2 Dry storage stabilizing composition for biological materials |
| 02/16/2012 | WO2012019354A1 Method for reducing dna impurities in viral compositions |
| 02/16/2012 | US20120040891 Hiv fusion inhibitor peptides with improved biological properties |
| 02/16/2012 | US20120040439 Use of Prokaryote Viruses to Remediate Bio-Fouling |
| 02/16/2012 | US20120040438 Novel Porcine Circovirus Type 2B Isolate and Uses Thereof |
| 02/16/2012 | US20120040329 Process For Continuous Production Of Bacteriophage |
| 02/16/2012 | US20120039978 Novel Anti-Viral Method |
| 02/16/2012 | US20120039939 Compositions and methods for vaccine and virus production |
| 02/16/2012 | US20120039936 Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (mva) |
| 02/16/2012 | US20120039921 Poultry viral materials and methods related thereto |
| 02/16/2012 | US20120039877 E1-minus adenoviruses and use thereof |
| 02/16/2012 | US20120039845 Nucleoside prodrugs and uses thereof |
| 02/16/2012 | US20120039802 Peptides that specifically bind hgf receptor (cmet) and uses thereof |
| 02/16/2012 | CA2807997A1 Dry storage stabilizing composition for biological materials |
| 02/15/2012 | EP2417258A1 Bacteriophage compositions for treatment of bacterial infections |
| 02/15/2012 | EP2417251A1 Method for purifying the rabies virus |
| 02/15/2012 | EP1532161B1 Vectors for expression of hml-2 polypeptides |
| 02/15/2012 | CN102352365A Method for clearing away mycoplasma from pseudorabies vaccine strains |
| 02/15/2012 | CN102352347A Porcin circovirus type 2 (PCV2) recombinant baculovirus construction method and subunit vaccine preparation method thereof |
| 02/15/2012 | CN102352346A Novel-pathotype duck reovirus and attenuated vaccine thereof |
| 02/15/2012 | CN102352345A Preparation method of newcastle disease HI antigen |
| 02/15/2012 | CN102351953A Virus filtration of liquid Factor VII compositions |
| 02/15/2012 | CN102350001A Preparation method of heterologous bluetongue virus double-strand RNA (ribonucleic acid) endogenous interferon inducer |
| 02/14/2012 | US8114637 Packaging cells for recombinant adenovirus |
| 02/14/2012 | US8114415 Method for producing temperature sensitive influenza A viruses |
| 02/14/2012 | CA2343135C Adenovirus vectors containing cell status-specific response elements and methods of use thereof |
| 02/09/2012 | WO2012018973A1 Inactivated varicella zoster virus vaccines, methods of production, and uses thereof |
| 02/09/2012 | WO2012016290A1 Modified hepatitis c virus proteins |
| 02/09/2012 | US20120035198 Antiviral Compounds and Methods of Using Thereof |
| 02/09/2012 | US20120034678 Diaryl Ethers |
| 02/09/2012 | US20120034677 Microorganism culture device and method of operation thereof |
| 02/09/2012 | US20120034676 Seneca valley virus based compositions and methods for treating disease |
| 02/09/2012 | US20120034673 Isolated plant deoxyhypusine synthase and nucleotides encoding same |
| 02/09/2012 | US20120034621 Microorganism concentration process and device |
| 02/09/2012 | US20120034267 Inactivated varicella zoster virus vaccines, methods of production, and uses thereof |
| 02/09/2012 | US20120034265 Influenza hemagglutinin and neuraminidase variants |
| 02/09/2012 | US20120034264 Influenza hemagglutinin and neuraminidase variants |
| 02/09/2012 | US20120034262 Bovine Herpes Virus-1 Compositions, Vaccines and Methods |
| 02/09/2012 | US20120034189 Means and methods for durable inhibition of pathogens |
| 02/09/2012 | CA2840993A1 Modified hepatitis c virus proteins |
| 02/09/2012 | CA2806454A1 Inactivated varicella zoster virus vaccines, methods of production, and uses thereof |
| 02/08/2012 | EP2415866A1 Vector utilizing borna disease virus and use thereof |
| 02/08/2012 | EP2415783A1 Modified vaccinia virus strains for use in a diagnostic and therapeutic method |
| 02/08/2012 | EP2414512A1 Enhanced production of papillomavirus-like particles with a modified baculovirus expression system |
| 02/08/2012 | EP2413963A1 Methods of use for hsv-1 and hsv-2 vaccines |
| 02/08/2012 | EP2413960A1 Diagnostic test for virus |
| 02/08/2012 | EP2413700A2 Methods for inactivating viruses |
| 02/08/2012 | EP1608393B1 Ebola peptides and immunogenic compositions containing same |
| 02/08/2012 | CN102344914A Construction and application of recombinant MDV (Marek's Disease Virus) strain for expressing REV env (Reticuloendotheliosis Viruses envelope) |
| 02/08/2012 | CN102344913A Construction of rabies virus G protein expression recombinant canine distemper virus CDV/R-20/8 vaccine strain |
| 02/08/2012 | CN102344912A Porcine pseudorabies virus strain and porcine pseudorabies inactivated vaccine prepared by using same |
| 02/08/2012 | CN102344911A Phage of Acinetobacter baumannii |
| 02/08/2012 | CN102343091A Ezrin phosphorylation-based material and application thereof |
| 02/08/2012 | CN101838658B O type foot-and-mouth disease virus variant as well as coding gene and application thereof |
| 02/08/2012 | CN101818163B 表达亚洲1型口蹄疫病毒vlp的重组腺病毒及其应用 FMD virus type Asia 1 expression vlp adenovirus and its application |
| 02/08/2012 | CN101180082B 利用siv-pedf载体治疗伴随眼组织细胞凋亡变性的疾患的药物 Use siv-pedf vehicle treated apoptotic degeneration associated with ocular tissue disorders drug |
| 02/07/2012 | US8110390 PRRS viruses, infectious clones, mutants thereof, and methods of use |
| 02/02/2012 | WO2012016044A1 Anti-viral azide containing compounds |
| 02/02/2012 | WO2011079073A3 Herpes simplex virus vaccines |
| 02/02/2012 | US20120028887 Lipopeptide inhibitors of hiv-1 |
| 02/02/2012 | US20120028880 Vegfr-1/nrp-1 targeting peptides |
| 02/02/2012 | US20120028357 Aav vectors produced in insect cells |
| 02/02/2012 | US20120028336 Single Recombination System and Methods of Use |
| 02/02/2012 | US20120028335 Anti-viral azide-containing compounds |
| 02/02/2012 | US20120027846 Anti-viral azide containing compounds |
| 02/02/2012 | US20120027797 Preservation of Bioactive Materials by Freeze Dried Foam |
| 02/02/2012 | US20120027792 Expression vectors able to elicit improved immune response and methods of using same |
| 02/02/2012 | US20120027790 Immunological herpes simplex virus antigens and methods for use thereof |
| 02/02/2012 | US20120027789 Antigenic peptide of hsv-2 and methods for using same |
| 02/02/2012 | US20120027788 Simian adenovirus nucleic acid- and amino acid-sequences, vectors containing same, and uses thereof |
| 02/02/2012 | US20120027777 Ljungan virus with improved replication characteristics |
| 02/01/2012 | EP2412242A2 Polynucleotides encoding antigenic HIV Type C polypeptides, polypeptides and uses thereof |
| 02/01/2012 | CN102341406A Assembly activating protein (aap) and its use for manufacture of parvovirus particles essential consisting of vp3 |
| 02/01/2012 | CN102337285A HIhh-containing retrovirus vector and virus particle, and application thereof |
| 02/01/2012 | CN102337251A Chimaera for HK97 bacteriophage virus-like particle and application of chimaera |
| 02/01/2012 | CN102337250A Infectious bovine rhinotracheitis virus strain and preparation method and application thereof |
| 02/01/2012 | CN102337249A Method for culturing various viruses by using MHV mixed cells |
| 02/01/2012 | CN102336822A Truncate human papilloma virus (HPV) 58 type L1 protein |
| 02/01/2012 | CN102335422A Recombinant phage peculiar smell removal vaccine for boars |
| 02/01/2012 | CN101805724B 靶向性wwox基因重组腺病毒及其制备方法和应用 Targeting wwox recombinant adenovirus and its preparation method and application |
| 02/01/2012 | CN101780278B 二联手足口病灭活疫苗 Two teamed foot mouth disease vaccine |
| 01/31/2012 | US8105825 Multiple inducible gene regulation system |
| 01/31/2012 | US8105767 Cells for detection of enteroviruses |
| 01/31/2012 | US8105609 Administering a vaccine of a nucleic acid having a transcriiptional unit (TU) to direct a host cell to to biosynthesize the matrix and envelope (M and E) protein antigens; the TU comprises a prM signal sequence and ribosomal bindng sequence; carriers; encephalitis and yellow fever |
| 01/31/2012 | US8105578 Administering interferon-sensitivity, replication-competent clonal Rna virus to mammals |
| 01/31/2012 | US8105574 Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use |
| 01/31/2012 | CA2432370C Attenuated flaviviral live vaccine comprising a capsid protein deletion |
| 01/31/2012 | CA2392221C Bovine immunodeficiency virus (biv) based vectors |
| 01/26/2012 | WO2012011969A1 High yield yellow fever virus strain with increased propagation in cells |
| 01/26/2012 | WO2012010280A1 Method for harvesting expression products |
| 01/26/2012 | US20120022232 Cells for increased protein expression comprising one or more release factors and methods of use |
| 01/26/2012 | US20120021507 Bioreactor and uses thereof |